# Biotech Growth Trust offers broad access to global drug innovation

- Link: https://www.directorstalkinterviews.com/biotech-growth-trust-offers-broad-access-to-global-drug-innovation/4121257388
- Published: 2026-07-22T09:59:00+01:00
- Author: Amilia Stone

Biotech Growth Trust invests in biotechnology companies worldwide, with the aim 
of delivering long-term capital growth. Managed by OrbiMed, the trust focuses on
businesses developing new medicines and healthcare technologies with clear scientific,
regulatory or commercial potential.

Portfolio manager Geoff Hsu has managed the trust since 2005. His approach is centred
on finding companies with strong science, capable management and identifiable events
that could increase value.

The current opportunity in biotechnology is supported by several factors. Innovation
remains strong, valuations in parts of the market are considered attractive, and
the US regulatory environment has been favourable towards new drug approvals. Merger
and acquisition activity is also providing support.

_**Biotech Growth Trust plc** (LON:BIOG) seeks capital appreciation through investment
in the worldwide biotechnology industry. The Company and the Company’s Portfolio
Manager believe that there is a high congruence between companies that seek to act
responsibly and those that succeed in building long-term shareholder value. _

Share on:
